EPRS

[البحــــر]

ليش واقف عن التداول وين الخبراء ؟

 

[Gulf Trader]

On July 26, 2016, EPIRUS Biopharmaceuticals, Inc. (the "Company") received a letter from the Nasdaq Stock Market ("Nasdaq") indicating that Nasdaq has determined that the Company's common stock, $0.001 par value per share (the "Common Stock") will be delisted from Nasdaq,